Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Elmet Group Co. (The) (ELMT)
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-11-04
$17.24-14.36%
Close 2026-11-05 · 1-day change
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
0.59 → 0.39 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ELMT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Supply high-performance refractory metals to U.S. defense agencies | A supporting condition in Elmet Group Co. (The)'s published investment case. The stated target is >=36 million in defense contracts. | Intact | defense contracts awarded fall below 36 million next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a smaller-cap industrial company with strategic expansion plans and exposure to cyclical sector conditions. The current long-term thesis is insufficiently supported by recent financial history, while management execution is described as volatile and overall risk remains elevated.
The evidence provides no valuation comparison or clear account of market expectations, so whether ELMT looks cheap, fair, or expensive versus peers cannot be assessed. Fragility is rated low, but that does not establish that expectations are modest.
Near term, results may remain uneven: operating cash flow was positive in 2026-Q1, while operating income was negative in 2027-Q2 and cash flow data for that period was not disclosed. Management is pursuing upstream tungsten partnerships and a European facility acquisition expected to close in Q1 2027, but the financial contribution of these plans is not yet shown.
Over the next one to three years, the thesis depends on management securing tungsten supply and completing the Schwabmünchen facility acquisition, then showing that these efforts support the business financially. Near-term conditions also matter: continued strength from industrial bellwethers could support the sector backdrop, while weaker bellwether results or further job-market weakness could pressure cyclical industrial companies.
ELMT has strategic plans that could strengthen its industrial position, but the limited financial evidence, mixed execution signals, and cyclical risks leave the one-to-three-year thesis uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Elmet Group Co. (The)'s published investment case. The stated target is complete acquisition by Q1 2027. |
| Intact |
| acquisition does not close by Q1 2027 |
Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Secure long-term tungsten supply through strategic partnerships | Elmet Group is expanding its tungsten supply chain through strategic partnerships. | Intact | revenue growth from tungsten partnerships falls below 10% next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.59 → $0.39 · observed estimates
$0.26B → $0.31B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-27 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-08-28 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-08-29 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-08-30 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-08-31 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-01 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-02 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-03 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-04 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-05 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-06 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-07 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-08 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-09 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-10 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-11 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-12 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-13 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-14 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-15 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-16 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-17 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-18 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-19 | $0.59 | $264,657,500 | 3 / 3 |
| 2026-09-20 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-21 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-22 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-23 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-24 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-25 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-26 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-27 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-28 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-29 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-09-30 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-10-01 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-10-02 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-10-03 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-10-04 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-10-05 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-10-06 | $0.59 | $264,782,500 | 3 / 3 |
| 2026-10-07 | $0.59 | $273,832,500 | 3 / 3 |
| 2026-10-08 | $0.64 | $273,832,500 | 3 / 3 |
| 2026-10-09 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-10 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-11 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-12 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-13 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-14 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-15 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-16 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-17 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-18 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-19 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-20 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-21 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-22 | $0.61 | $273,907,500 | 3 / 3 |
| 2026-10-23 | $0.61 | $273,907,500 | 2 / 3 |
| 2026-10-24 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-10-25 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-10-26 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-10-27 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-10-28 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-10-29 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-10-30 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-10-31 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-11-01 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-11-02 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-11-03 | $0.39 | $305,107,500 | 2 / 3 |
| 2026-11-04 | $0.39 | $305,107,500 | 2 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 3 recorded
3 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.